Market

Ratio Analysis

You can view the Ratio Analysis for the last 5 years.

RATIOS

Fredun Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 344.19 P/BV 2.63 Book Value ( ₹ ) 277.17
52 Week High/Low ( ₹ ) 956/635 FV/ML 10/1 P/E(X) 16.54
Book Closure 30/09/2024 EPS ( ₹ ) 44.07 Div Yield (%) 0.10

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)44.8333.6624.1311.285.05
Diluted EPS (Rs.)44.8333.3222.9311.285.05
Cash EPS (Rs.)53.4941.3230.0419.1610.07
Book Value[Excl.RevalReserv]/Share (Rs.)299.47258.49212.64153.54107.96
Book Value[Incl.RevalReserv]/Share (Rs.)299.47258.49212.64153.54107.96
Dividend / Share (Rs.)0.700.700.700.700.70
Revenue From Operations / Share (Rs.)956.66740.88606.04506.38335.60
PBDIT / Share (Rs.)116.6982.7865.3134.8026.41
PBIT / Share (Rs.)107.2774.7059.1129.9321.39
PBT / Share (Rs.)59.8745.6538.6319.408.04
Net Profit / Share (Rs.)44.0733.2523.8414.295.05
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)12.1911.1710.776.877.86
PBIT Margin (%)11.2110.089.755.916.37
PBT Margin (%)6.256.166.373.832.39
Net Profit Margin (%)4.604.483.932.821.50
Return on Networth / Equity (%)14.7112.8611.219.304.67
Return on Capital Employeed (%)31.7824.9317.7211.7111.35
Return On Assets (%)4.275.074.203.381.24
Long Term Debt / Equity (X)0.060.100.500.610.67
Total Debt / Equity (X)1.180.860.890.770.92
Asset Turnover Ratio (%)1.141.231.241.290.90
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.311.542.042.071.50
Quick Ratio (X)0.570.490.621.440.72
Inventory Turnover Ratio (X)1.561.752.513.111.71
Dividend Payout Ratio (NP) (%)0.002.092.884.8913.30
Dividend Payout Ratio (CP) (%)0.001.682.283.656.67
Earning Retention Ratio (%)0.0097.9197.1295.1186.70
Cash Earning Retention Ratio (%)0.0098.3297.7296.3593.33
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)2.462.853.193.302.53
Interest Coverage Ratio (Post Tax) (%)1.932.142.162.361.76
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)477.26441.23435.36456.41223.45
EV / Net Operating Revenue (X)1.061.271.592.031.67
EV / EBITDA (X)8.6611.3414.7129.5921.21
MarketCap / Net Operating Revenue (X)0.690.961.281.811.38
Retention Ratios (%)0.0097.9097.1195.1086.69
Price / BV (X)2.232.773.665.964.29
Price / Net Operating Revenue (X)0.690.961.281.811.38
EarningsYield0.060.040.030.010.01